UnknownNot Applicable

Fuzheng Nizeng Formula for Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia, a Multicenter Randomized Controlled Trial

China144 participantsStarted 2022-10-24

Plain-language summary

Fuzheng Nizeng Formula (FZNZ) is derived from the classic formula Liujunzi Decoction. Former pilot study found that FZNZ promoted the recovery of gastric atrophy and relieve the relative symptoms. This study is to evaluate its efficacy for chronic atrophic gastritis with low-grade intraepithelial neoplasia, compared with positive control Molduodan granule.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia diagnosed by endoscopy and stomach biopsy. * Helicobacter pylori negative. * TCM syndrome is spleen-stomach deficiency with blood stasis and phelgm. Exclusion Criteria: * History of gastric surgery. * Combined with malignant tumor. * History of mental illness. * Allergy to any components of the drug use in the study. * Planning to pregnancy, or pregnant woman and lactating woman.

What they're measuring

Recovery rate of Low-grade Intraepithelial Neoplasia

Timeframe: The 180 days after drug administration.

Trial details

NCT IDNCT06324825

SponsorPeking University First Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-31

View on ClinicalTrials.gov More Atrophic Gastritis With Low-grade Intraepithelial Neoplasia trials